Results 221 to 230 of about 3,206,200 (405)

Recurrent Goiter, Hyperthyroidism, Galactorrhea and Amenorrhea due to a Thyrotropin ans Prolactin-Producing Pituitary Tumor [PDF]

open access: yes, 1976
Erhardt, F.   +5 more
core   +1 more source

Outcomes of Sequential Immune Checkpoint Inhibitor Retreatment After Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma

open access: yesJournal of Gastroenterology and Hepatology, EarlyView.
ABSTRACT Background and Aim Data on sequential immune checkpoint inhibitor (ICI) retreatment following initial atezolizumab plus bevacizumab (Atez + Bev) are limited. This study aimed to evaluate the efficacy and safety of sequential ICI retreatment in patients with unresectable hepatocellular carcinoma (uHCC). Methods Of 835 patients with uHCC treated
Takanori Ito   +24 more
wiley   +1 more source

Spindle cell oncocytoma of the pituitary and pituicytoma: Two tumors mimicking pituitary adenoma

open access: green, 2011
Hideki Ogiwara   +4 more
openalex   +2 more sources

Intrasellar pressure and tumor volume in pituitary tumor: relation study [PDF]

open access: gold, 2006
Jackson A. Gondim   +2 more
openalex   +1 more source

Prevalence of Antenatally Identified Lactation Risk Factors and Risk of Not Fully Breastfeeding at 6 to 8 Weeks Postpartum

open access: yesJournal of Midwifery &Women's Health, EarlyView.
Introduction Several anatomical and endocrine factors have been linked to breastfeeding difficulties, yet there is limited evidence for their prevalence and associated postpartum breastfeeding outcomes. Knowledge of the prevalence and impact of nonmodifiable lactation risk factors can inform clinical care.
Sharon L. Perrella   +3 more
wiley   +1 more source

68Ga-DOTATOC PET/CT in the Localization of Pituitary Tumors in Cushing's Disease. [PDF]

open access: yesEndocrinol Metab (Seoul)
Kim K   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy